| # | Drug | Count |
|---|---|---|
| 0 | CANAGLIFLOZIN | 114 |
| 1 | ALENDRONATE SODIUM | 77 |
| 2 | PREDNISONE | 61 |
| 3 | METHOTREXATE SODIUM | 35 |
| 4 | METHOTREXATE | 32 |
| 5 | ASPIRIN | 30 |
| 6 | MYCOPHENOLATE MOFETIL | 28 |
| 7 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 28 |
| 8 | ASPIRIN 325 MG | 26 |
| 9 | ASPIRIN 81 MG | 26 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PAMIDRONATE DISODIUM | 19 | 0.0056 |
| 1 | CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 8 | 0.0044 |
| 2 | CANAGLIFLOZIN | 114 | 0.0038 |
| 3 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 8 | 0.0029 |
| 4 | CLINDAMYCIN PHOSPHATE | 13 | 0.0024 |
| 5 | BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | 1 | 0.0022 |
| 6 | PSYLLIUM HUSK | 3 | 0.0022 |
| 7 | EQUINE THYMOCYTE IMMUNE GLOBULIN | 2 | 0.0019 |
| 8 | VANCOMYCIN HYDROCHLORIDE | 15 | 0.0018 |
| 9 | CALCITONIN SALMON | 4 | 0.0013 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 106 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 64 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 48 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 32 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 30 |
| 5 | Vitamin C [EPC] | 30 |
| 6 | Aromatase Inhibitor [EPC] | 28 |
| 7 | Benzodiazepine [EPC] | 26 |
| 8 | Vitamin D [EPC] | 26 |
| 9 | Alkylating Drug [EPC] | 25 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Calcitonin [EPC] | 4 | 0.0013 |
| 1 | CD19-directed Cytolytic Antibody [EPC] | 1 | 0.0012 |
| 2 | Interferon gamma [EPC] | 1 | 0.0007 |
| 3 | Provitamin D2 Compound [EPC] | 16 | 0.0005 |
| 4 | Monobactam Antibacterial [EPC] | 1 | 0.0004 |
| 5 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 8 | 0.0004 |
| 6 | Antimetabolite Immunosuppressant [EPC] | 7 | 0.0003 |
| 7 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 1 | 0.0003 |
| 8 | Human Immunoglobulin G [EPC] | 6 | 0.0003 |
| 9 | Sulfone [EPC] | 3 | 0.0003 |